Previous 10 | Next 10 |
Palm Beach, FL – October 4, 2022 – FinancialNewsMedia.com News Commentary – The laser therapy market has been having a very health growth trend in recent years and is expected to continue through the coming years. Minimally invasive surgical procedures...
Summary Cutera has flown under the radar in FY22 after collapsing from 52-week highs back in April. Shares look unfairly compressed and have recently tested long-term resistance levels. Noteworthy is that Cutera's revenue is largely protected from CMS/reimbursement overhang, g...
AviClear becomes the fastest adopted device in Cutera’s history Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announces that over 1,000 AviClear laser treatments have been performed in the Uni...
Cutera, Inc. (CUTR) Q2 2022 Results Conference Call August 04, 2022 04:15 PM ET Company Participants Dave Mowry - CEO Rohan Seth - CFO Conference Call Participants Jon Block - Stifel Chris Cooley - Stephens Louise Chen - Cantor Presentation ...
Image source: The Motley Fool. Cutera (NASDAQ: CUTR) Q2 2022 Earnings Call Aug 04, 2022 , 4:15 p.m. ET Operator Continue reading For further details see: Cutera (CUTR) Q2 2022 Earnings Call Transcript
Cutera press release ( NASDAQ: CUTR ): Q2 GAAP EPS of -$2.53 misses by $2.12 . Revenue of $64.2M (+9.6% Y/Y) beats by $0.78M . Management reiterates full-year revenue guidance vs. previous forecast of $255M to $260M. The consensus revenue estimate is $261.3...
Record second-quarter revenue driven by ongoing momentum in Capital Equipment and Consumable Product segments Over one hundred new patients treated during the first quarter of AviClear’s availability Management reiterates full-year revenue guidance despite $15 m...
Stocks continue to trend higher with the S&P 500 trading near a 3-month high. We are bullish and expect more upside into what could be an accelerating market-wide short squeeze. We highlight five stock ideas that are ready to break out. All the talk in the market rig...
Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the second quarter after the market close on Thursday, August 4, 2022. The C...
The First and Only Device in North America Cleared for the Treatment of Mild, Moderate and Severe Acne AviClear has been Proven Safe and Effective Through an Extensive Clinical Trial Provides Long-term Resolution of Acne Across All Skin Types Cutera, Inc....
News, Short Squeeze, Breakout and More Instantly...
CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced today that it will report financial results for the second quarter ended June 30, 2024, after the market closes on Thursday, August 8, 2024. The Company’s management will host a conference...
New insights reveal the profound impact of acne and the growing interest in modern treatments Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announces the release of important new acne survey data as part of June’s Acne Awareness Month. Th...
Experienced Healthcare Executive Brings Extensive Financial and Operational Expertise to Cutera Board of Directors CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced today that Jeryl “Jeri” Hilleman will join its Board of Direct...